Company / Operating Income per Share
CUMBERLAND PHARMACEUTICALS INC Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.09
FY2025
5-year range
-$0.68 / $0.09
FY2021-FY2025
Trend
+113.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-0.68 in FY2024 to $0.22 in FY2016.
Based on SEC 10-K filings.
0.09 in FY2025.
Improved from $-0.40 to $0.09 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 113.7% year-over-year.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +113.7% |
| FY2024 | -$0.68 | -70.4% |
| FY2023 | -$0.40 | +23.7% |
| FY2022 | -$0.52 | +16.0% |
| FY2021 | -$0.62 | -48.2% |
| FY2020 | -$0.42 | +30.3% |
| FY2019 | -$0.60 | -572.9% |
| FY2018 | -$0.09 | -228.9% |
| FY2017 | $0.07 | -68.2% |
| FY2016 | $0.22 | +197.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026